Scandinavian ChemoTech strengthens finances by raising a loan of 2.5 MSEK from board and CEO
The Company has today entered into an agreement to strengthen its working capital by raising a loan from four of its board members including CEO.The agreement signed today strengthens the Company's finances to ensure its ongoing operations. The loan is taken out at an interest rate of 4% per quarter on the granted loan. The lenders will be given the opportunity to use all or part of the disbursed loan, including accrued and unpaid interest, as an offset in the event of a new issue. “I appreciate the support from the board to extend our operations into 2023 which gives us